Hims & Hers Health (HIMS) vs LifeStance Health Group (LFST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
LifeStance Health Group (LFST) has outperformed Hims & Hers Health (HIMS) over the past year, gaining 119.0% versus a loss of 49.0%. Over five years, HIMS leads with a +253.3% price change compared with +5.3% for LFST. Hims & Hers Health is the larger company by market cap ($6.89 billion vs $4.60 billion), about 1.5 times the size.
On valuation, LifeStance Health Group trades at a lower forward P/E (28.1x vs 40.1x for Hims & Hers Health). Hims & Hers Health converts more of its revenue into profit, with a net margin of 5.5% versus 0.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HIMS | LFST |
|---|---|---|
| Share price | $29.54 | $12.11 |
| Market cap | $6.89B | $4.60B |
| 1-day change | +0.24% | -0.08% |
| YTD return | -9.02% | +72.02% |
| 1-year return | -49.04% | +118.99% |
| 5-year return | +253.35% | +5.30% |
| P/E ratio (TTM) | — | 93.15 |
| Forward P/E | 40.07 | 28.11 |
| EPS (TTM) | $-0.64 | $0.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.35B | $1.42B |
| Revenue growth (YoY) | +59.00% | +13.85% |
| Net income (latest FY) | $128.37M | $9.66M |
| Gross margin | 73.84% | — |
| Operating margin | 4.50% | 1.70% |
| Net margin | 5.47% | 0.68% |
| 52-week high | $65.30 | $13.56 |
| 52-week low | $13.74 | $4.77 |
| Distance from 52-week high | -54.76% | -10.69% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +5.45% | +18.91% |
| Average volume | 11.96M | 4.36M |
| Shares outstanding | 224.94M | 380.15M |
| Employees | 2,442 | 8,542 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LFST has outperformed HIMS by 168.0 percentage points over the past year.
- Hims & Hers Health grew revenue faster in its latest fiscal year (+59.00% vs +13.85%).
About Hims & Hers Health
HIMS stock →Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally.
Health Care · Medical/Nursing Services · 2,442 employees
About LifeStance Health Group
LFST stock →LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Health Care · Medical/Nursing Services · 8,542 employees
HIMS vs LFST FAQ
Which is bigger, Hims & Hers Health or LifeStance Health Group?
Hims & Hers Health (HIMS) is larger, with a market capitalization of $6.89B compared with $4.60B for LifeStance Health Group (LFST).
Which stock has performed better over the past year, HIMS or LFST?
LFST returned +118.99% over the past 12 months, compared with -49.04% for HIMS (price return, excluding dividends). Past performance does not predict future results.
Are Hims & Hers Health and LifeStance Health Group in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.